Top

Journal of Neuro-Oncology

Published in:

01-12-2014 | Letter to the Editor

Letter to the Editor: “The role of imaging in the management of progressive glioblastoma. A systematic review and evidence-based clinical practice guideline” [J Neurooncol 2014; 118:435–460]

Authors: Karl-Josef Langen, Jörg C. Tonn, Michael Weller, Norbert Galldiks

Published in: Journal of Neuro-Oncology | Issue 3/2014

Excerpt

To the Editor, …

Ryken TC, Aygun N, Morris J, Schweizer M, Nair R, Spracklen C, Kalkanis SN, Olson JJ (2014) The role of imaging in the management of progressive glioblastoma. A systematic review and evidence-based clinical practice guideline. J Neurooncol 118:435–460PubMedCrossRef

Heiss WD (2014) Clinical impact of amino acid PET in gliomas. J Nucl Med. doi:10.2967/jnumed.114.142661

Langen KJ, Hamacher K, Weckesser M, Floeth F, Stoffels G, Bauer D et al (2006) O-(2-[18F]fluoroethyl)-l-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol 33:287–294PubMedCrossRef

Rachinger W, Goetz C, Popperl G, Gildehaus FJ, Kreth FW, Holtmannspotter M et al (2005) Positron emission tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas. Neurosurgery 57:505–511PubMedCrossRef

Popperl G, Kreth FW, Herms J, Koch W, Mehrkens JH, Gildehaus FJ et al (2006) Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods? J Nucl Med 47:393–403PubMed

Galldiks N, Stoffels G, Filss CP, Piroth MD, Sabel M, Ruge MI et al (2012) Role of O-(2-18F-Fluoroethyl)-l-Tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis. J Nucl Med 53:1367–1374PubMedCrossRef

Galldiks N, Langen K, Holy R, Pinkawa M, Stoffels G, Nolte K et al (2012) Assessment of treatment response in patients with glioblastoma using [18F]Fluoroethyl-l-Tyrosine PET in comparison to MRI. J Nucl Med 53:1048–1057PubMedCrossRef

Pöpperl G, Götz C, Rachinger W, Schnell O, Gildehaus FJ, Tonn JC et al (2006) Serial O-(2-[(18)F]fluoroethyl)-l-tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant glioma. Eur J Nucl Med Mol Imag 33:792–800CrossRef

Popperl G, Goldbrunner R, Gildehaus FJ, Kreth FW, Tanner P, Holtmannspotter M et al (2005) O-(2-[18F]fluoroethyl)-l-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma. Eur J Nucl Med Mol Imag 32:1018–1025CrossRef

10.

Galldiks N, Rapp M, Stoffels G, Fink GR, Shah NJ, Coenen HH et al (2013) Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-l-tyrosine PET in comparison to MRI. Eur J Nucl Med Mol Imag 40:22–33CrossRef

11.

Hutterer M, Nowosielski M, Putzer D, Waitz D, Tinkhauser G, Kostron H et al (2011) O-(2-18F-fluoroethyl)-l-tyrosine PET predicts failure of antiangiogenic treatment in patients with recurrent high-grade glioma. J Nucl Med 52:856–864PubMedCrossRef

12.

Herrmann K, Czernin J, Cloughesy T, Lai A, Pomykala KL, Benz MR et al (2014) Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients. Neuro-oncology 16:603–609PubMedCrossRef

13.

Pauleit D, Floeth F, Tellmann L, Hamacher K, Hautzel H, Muller HW et al (2004) Comparison of O-(2-18F-fluoroethyl)-l-tyrosine PET and 3-123I-iodo-alpha-methyl-l-tyrosine SPECT in brain tumors. J Nucl Med 45:374–381PubMed

Title: Letter to the Editor: “The role of imaging in the management of progressive glioblastoma. A systematic review and evidence-based clinical practice guideline” [J Neurooncol 2014; 118:435–460]
Authors: Karl-Josef Langen
Jörg C. Tonn
Michael Weller
Norbert Galldiks
Publication date: 01-12-2014
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 3/2014
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-014-1594-z

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Letter to the Editor: “The role of imaging in the management of progressive glioblastoma. A systematic review and evidence-based clinical practice guideline” [J Neurooncol 2014; 118:435–460]

Excerpt

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2014

Low-dose rate stereotactic iodine-125 brachytherapy for the treatment of inoperable primary and recurrent glioblastoma: single-center experience with 201 cases

Incidence of medulloblastoma in Canadian children

Pure germinomas of the central nervous system: treatment strategies and outcomes

Toxicity of tandem high-dose chemotherapy and autologous stem cell transplantation using carboplatin-thiotepa-etoposide and cyclophosphamide-melphalan regimens for malignant brain tumors in children and young adults

The ophthalmic natural history of paediatric craniopharyngioma: a long-term review

Impact of health-related quality of life and fatigue on survival of recurrent high-grade glioma patients